SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Ward Knutson who wrote (15065)1/3/2005 12:24:37 PM
From: Biomaven  Respond to of 52153
 
which there clearly was not with rubitecan

There wasn't cleary anything with rubitecan. They never disclosed much of anything. Maybe they will now given they no longer have the FDA figleaf.

When I said the bar is low, I meant that nothing currently prolongs survival, so even a small effect might be enough to convince the FDA. Can't argue about your case for gem.

Peter